Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Science Immunology|May 13, 2022
Immune recall improves antibody durability and breadth to SARS-CoV-2 variantsYuezhou Chen, Pei Tong, Noah Whiteman, et al.Biorxiv : the Preprint Server for Biology|September 30, 2020
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroTianshu Xiao, Jianming Lu, Jun Zhang, et al.Nature Structural & Molecular Biology|January 12, 2021
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agentTianshu Xiao, Jianming Lu, Jun Zhang, et al.Cell Reports|April 22, 2022
Structural and functional impact by SARS-CoV-2 Omicron spike mutationsJun Zhang, Yongfei Cai, Christy L Lavine, et al.Biorxiv : the Preprint Server for Biology|August 24, 2021
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variantJun Zhang, Tianshu Xiao, Yongfei Cai, et al.Science (New York, N.Y.)|October 26, 2021
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variantJun Zhang, Tianshu Xiao, Yongfei Cai, et al.Biorxiv : the Preprint Server for Biology|August 4, 2020
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 ReceptorPeng Zhao, Jeremy L Praissman, Oliver C Grant, et al.Cell Host & Microbe|August 26, 2020
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 ReceptorPeng Zhao, Jeremy L Praissman, Oliver C Grant, et al.Science Advances|December 8, 2022
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivoJames A Torchia, Alexander H Tavares, Laura S Carstensen, et al.Biorxiv : the Preprint Server for Biology|April 21, 2021
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variantsYongfei Cai, Jun Zhang, Tianshu Xiao, et al.Pageof 4